
Rural medicine in Chamberlain shaped by the FARM program
Jan. 30—CHAMBERLAIN, S.D. — On her last day at Sanford Chamberlain Medical Center, Emily Kirschenmann walked through the hospital doors, just as she had hundreds of times during the past 11 months. But this time, something was different. As she stepped out into the crisp air, the weight of the experience hit her all at once. The small town she'd come to call home, the patients who had trusted her with their care and the doctors who had mentored her through it all were now part of her story. And it was hard to say goodbye.
"I've walked through those doors so many times, but today it felt different," she said. "I've built relationships with my patients, with the staff, with the community. It's hard to walk away from something that's meant so much to me."
Kirschenmann's experience in Chamberlain was part of the University of South Dakota Sanford School of Medicine's Frontier And Rural Medicine (FARM) program. Launched in 2014, Launched in 2014, the program immerses medical students like Kirschenmann in rural healthcare environments, allowing them to gain hands-on experience in family medicine and primary care in underserved areas. The goal is to address the shortage of doctors in rural communities by fostering long-term careers in rural healthcare.
Chamberlain, which joined the FARM network in 2024, offers a distinctive setting for students like Kirschenmann to grow. Located along the Missouri River, it provides students with not only clinical training but also a chance to engage with the community on a deeper level. The town's size and diversity make it an ideal site for the program.
"Sanford Chamberlain's facilities and physicians make the location a good addition to the program," said Janet Fulk, assistant director of the FARM program. "Our FARM students will benefit from the proximity to the interstate and diverse patient population, along with accessibility to a wide variety of clinical experiences."
For Kirschenmann, who grew up in Dell Rapids, joining the FARM program felt like a natural fit. She was exposed to the program long before medical school. At 18, she had the chance to observe the program firsthand through her aunt, Dr. Anora Henderson, who administered the FARM site in Winner. Kirschenmann had the opportunity to job shadow her aunt and see how a FARM student interacted with patients. Her cousin, Katie Dorn, also participated in the program in Spearfish.
"Watching my aunt work with a FARM student really showed me the kind of relationship I want to have with my attending physician," she said. "It's not just about teaching; it's about mentorship and truly caring for your students, helping them grow as both doctors and people."
Her training in Chamberlain was far from typical. Over the course of the year, Kirschenmann followed patients through every stage of their care, from clinic visits to hospital stays, witnessing struggles and triumphs.
"It's the little moments that stick with you," she said. "Like when a patient thanked me for being there during their procedure. It wasn't about doing something big — it was just being part of their journey."
In addition to clinical work, students in the FARM program are required to engage with the community. Kirschenmann took part in local outreach efforts, including speaking at the Freshman Impact event, where she educated high school students about the dangers of nicotine use.
The FARM program continues to expand, now with seven locations statewide, including Milbank, Mobridge, Parkston, Pierre, Spearfish, and Vermillion. In 2024, 13 students participated in the program. The addition of Chamberlain reflects the program's growth and success in training doctors for rural communities.
"This program is making a real difference," said Tim Ridgway, Dean of the Sanford School of Medicine. "In the 10 years since we've had students complete the program, 75% have gone into primary care specialties. That's huge. By every metric, FARM is killing it."
Ridgway also noted an exciting development in the program's evolution: prior FARM students are now returning to the same rural sites where they trained to become full-time employees after completing medical school.
While Chamberlain's addition to the FARM network has been a success, the program faced a challenge with the loss of Winner, a site that had been part of the initiative from the beginning. The closure of Winner's OB department made it no longer viable for FARM students. However, the program's broader impact remains strong.
"Living in a rural town and practicing medicine here really opened my eyes to the challenges patients face, especially when they need specialized care," Kirschenmann said. "Sometimes, a two-hour drive is needed to see a specialist, and that can be tough for patients."
Kirschenmann's year in Chamberlain shaped her broader perspective on medicine.
"Being part of the FARM program has given me a holistic way to practice," Kirschenmann said. "I've seen my patients in the community, in the clinic, and in the hospital. It's made me a better doctor and a better person."
As she prepares to return to Sioux Falls for her remaining medical training and apply for residency, she carries with her the lessons of rural medicine — a deeper understanding of its challenges and rewards, and a stronger commitment to family medicine.
"As I prepare to take the next step in my medical career, I carry with me the lessons I've learned here — how to navigate the complexities of rural healthcare, and how deeply rewarding it is to build lasting relationships with patients and the community," Kirschenmann said. "Chamberlain has shown me what it truly means to be part of a community, and I hope to return someday."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29-05-2025
- Yahoo
Rep. Dusty Johnson speaks to students in Vermillion about moves being made in Washington
VERMILLION, S.D. (KCAU) — This week, South Dakota's representative stepped away from Capitol Hill to speak with students in Vermillion. Wednesday morning, Representative Dusty Johnson answered questions from students at the University of South Dakota. The students are members of the American Legion Auxiliary's Girls State Program, which helps girls get involved in government and volunteering. Story continues below Top Story: Midwest Honor Flight still raising money for June 3 trip Lights & Sirens: Officials searching for Monona County resident after going missing on Missouri River Sports: Dell Rapids claims SDHSBA Class B title with 5-4 win over Dakota Valley in eight innings Weather: Get the latest weather forecast here While Johnson was visiting, many of the same topics were brought up, including concerns about cuts to Medicaid. He said most folks won't be impacted. 'If you're on the program [as] an illegal alien, you're going to have a problem. If you are an able-bodied, young person without dependence at home [or] if you're a 27-year-old who can work but chooses not to, yes. Our work requirements are going to require you to volunteer, go to school, get in a training program, or go to work, and we do that because we want you to improve your life,' Rep. Johnson said. South Dakota Governor Larry Rhoden also answered questions from the students at USD on Wednesday. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Yahoo
23-05-2025
- Yahoo
Parkston's Wickersham appointed to Rural Medicine dean role at Sanford School of Medicine
May 22—PARKSTON, S.D. — Dr. Jason Wickersham has been named Associate Dean of Rural Medicine at the Sanford School of Medicine (SSOM), a position he has held on an interim basis since April 2024. In addition to this role, he will continue practicing family medicine at Avera St. Benedict Health Center in Parkston. In the position of associate dean of rural medicine, Wickersham will help advance the school's mission to provide a workforce pipeline for rural South Dakota. He will collaborate with rural physicians, ensuring that medical students have meaningful experiences in rural areas, and design and support pathway programs that introduce the youth of rural South Dakota to medical careers. Wickersham will also provide leadership and oversight of all academic, research and public service programs for rural medicine sites, while fostering student professionalism and ethical behavior, and mentoring academic and clinical faculty. A 2001 graduate of the Sanford School of Medicine, Wickersham completed his residency at the Nebraska Medical Center's Clarkson Family Practice Residency Program in Omaha, Neb. He was named the 2025 Physician of the Year by the South Dakota Academy of Family Physicians, and in 2023 he was given the Edward J. Batt, M.D., Memorial Teaching Award from the SSOM. Wickersham is a member of Alpha Omega Alpha Honor Society, the American Medical Association and the American Academy of Family Physicians, at both the state and national levels. He also serves on the Avera Health Board of Directors and the SDSMA PAC Board of Directors.
Yahoo
02-05-2025
- Yahoo
What to know about weight-loss jabs and NHS pharmacy plans
NHS patients could be prescribed weight-loss jabs by pharmacies, according to new reports. Currently, weight-loss injections are only available on the NHS after talks with a specialist and are restricted to those with the highest clinical need. But reports suggest injections like Mounjaro and Wegovy could be made available after a short consultation with a pharmacist, for the £9.90 cost of an NHS prescription. At present, the drugs can be bought privately from high street chemists and online pharmacies after an in-person or video consultation with a specialist. A private prescription can cost upwards of £150 a month. It's estimated more than half a million people are getting injections this way because of the long wait time for specialist NHS clinics. The National Institute for Health and Care Excellence (NICE) previously set out plans for a gradual roll-out of the drugs on the NHS to avoid overwhelming the service, meaning not everyone who is eligible for the medication can access it straight away. If it goes ahead, the planned government trial would help tackle obesity by allowing more people to get access to injections. However, the reports are still speculative. The Telegraph states that, "The Department for Science, Innovation and Technology is expected to announce plans to try new ways to prescribe and monitor use of the medication." But added that a spokesperson would not confirm the details. Last month, Jeremy Clarkson, shared some of the challenging side effects of weight-loss jabs revealing Ozempic left him "sick a lot". Writing in a column for The Sunday Times, the 64-year-old broadcaster said he started taking the weight-loss drug two years ago, but gave up taking it after finding it wasn't having a positive impact on him. "My body lost the ability to deal with gluttony but once the initial enthusiasm had worn off, my mind still wanted to breakfast on Cadbury Fruit & Nut," he wrote. "This meant I was sick a lot. And after I had vomited, I figured I was empty and could have another bottle and maybe another bar of chocolate too." The Clarkson's Farm star went on to add "Ozempic turned me into a bulimic version of Henry VIII." -After swapping Ozempic for another weightloss drug, Mounjaro, which he jokingly called "Muntjac", Clarkson said that while he was yet to lose weight, he felt it was "inevitable" that he would soon. But Mounjaro also comes with some compromises, with the presenter admitting he is struggling with not being able to enjoy his favourite meals as his appetite has been suppressed. "You find yourself living a minibar existence," he wrote, joking that a "handful of sunflower seeds" would be enough to keep him full. "That's not living. That's existing." Weight-loss jabs have become increasingly high-profile after a number of celebrities, like Clarkson, began using Ozempic, which is primarily used to treat type 2 diabetes, to lose significant amounts of weight. But there have been some safety concerns after figures from the Medicines and Healthcare products Regulatory Agency (MHRA) revealed a rise in the number of deaths linked to weight loss and diabetes drugs. The figures show that of the 82 deaths, 60 were linked to the use of medications like Ozempic and Mounjaro for treating type 2 diabetes, while 22 were linked to using it for weight loss. Earlier this year, online pharmacies were told they must conduct a proper two-way consultation with patients before prescribing weight loss jabs The General Pharmaceutical Council (GPhC), which regulates pharmacies, said it was responding to concerns relating to the unsafe prescribing and supply of medicines like weight loss jabs online. Wegovy is the brand name for semaglutide which is licensed and approved for managing obesity. It differs from Ozempic, which is another brand name for semaglutide and is used for treating type 2 diabetes. Ozempic should not be prescribed solely for weight loss. The NHS began offering Wegovy in September 2023 as an option for weight management in line with guidance from the National Institute for Health and Care Excellence (NICE). It is recommended that the medication be used in tandem with a reduced-calorie diet and increased physical activity. You are eligible for Wegovy if you meet the following criteria: Have a Body Mass Index (BMI) of at least 35 One weight-related comorbidity (such as hypertension of cardiovascular disease) Have a BMI of 30 to 34.9, provided you meet the criteria for referral to specialist weight management services The Department for Health and Social Care adds: "Wegovy is for those dealing with obesity and weight-related problems, not for people who just want to lose some weight." Wegovy is taken via an injection once a week. Should you meet the eligibility criteria and are prescribed Wegovy, your healthcare team will give you more information about how to take it and how to inject it. Mounjaro is approved for weight loss and weight management in adults aged 18 and over who meet the eligibility criteria. It works by regulating a person's appetite so they feel full, making them feel less hungry and experience fewer food cravings. It is recommended that Mounjaro be used together with a reduced-calorie diet and increased physical activity. You are eligible for Mounjaro if you meet the following criteria: Have a BMI of at least 30 Have a BMI between 27 to 30, and weight-related problems such as prediabetes, high blood pressure, high cholesterol, or heart problems Mounjaro is available as a pre-filled injection pen that is to be injected under the skin of your stomach area, thigh or upper arm. The starting dose is 2.5mg once a week for four weeks, increasing to 5mg once a week. According to the Medicines and Healthcare products Regulatory Agency (MHRA), the dose may then be increased in at least four-week intervals up to the maximum dose of 15mg per week. Women using oral contraceptives may be advised to consider using a barrier method of contraception, such as a condom or switching to a non-oral contraceptive method for four weeks after starting Mounjaro. This is because Mounjaro may affect the efficacy of the contraceptive pill. You can get both Wegovy and Mounjaro via a private prescription in the UK. Neither medication is available over the counter from a pharmacy, as you will need to be assessed for suitability before being given a prescription. You should also get ongoing support from the prescriber. However, the National Pharmacy Association (NPA) warned last year of a possible "explosion in the unlicensed sale of medication online" and urged people not to take the risk of buying weight loss injections without proper checks. The NPA advised patients to speak to their GP about whether they are eligible for and should have a prescription for weight loss drugs. The warning came after the MHRA reported that nearly 50 people were hospitalised after using weight loss drugs last year. The MHRA said prescription-only medications such as Wegovy and Mounjaro are "effective and acceptably safe when used within their licensed indications", adding that there are still "risks associated with their use'. "When appropriately used in line with the product license, the benefits of these medications outweigh the risks for patients," said the regulatory agency. "However, this benefit-risk balance is positive only for patients within the approved indications for weight management or type 2 diabetes as described in the product information." Additional reporting by PA Read more about weight loss: Who can get new weight-loss jab Mounjaro on the NHS? (Yahoo Life UK, 4-min read) Alison Hammond reveals why she is 'frightened' of weight loss medications (Yahoo Life UK, 3-min read) Obesity rates may start falling this year due to weight loss jabs, seller says (Sky News, 4-min read)